Sign In
Buy NUVA
$39.75
+0 (+0%)
At Close: Nov 30, 2023
NuVasive Announces Conference Call and Webcast of Third Quarter 2022 Results
07:00am, Tuesday, 25'th Oct 2022
SAN DIEGO , Oct. 25, 2022 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integr
Benzinga's Top Ratings Upgrades, Downgrades For October 18, 2022
02:21pm, Tuesday, 18'th Oct 2022 Benzinga
Upgrades
According to Jefferies, the prior rating for Target Corp (NYSE:TGT) was changed from Hold to Buy. Target earned $0.39 in the second quarter, compared to $3.64 in the year-ago quarter. The cur
Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2022
02:02pm, Wednesday, 12'th Oct 2022 Benzinga
Upgrades
For CME Group Inc (NASDAQ:CME), Deutsche Bank upgraded the previous rating of Hold to Buy. In the second quarter, CME Group showed an EPS of $1.97, compared to $1.64 from the year-ago quarte
Tilray To Crater Over 30%? Here Are 5 Other Price Target Changes For Friday
12:28pm, Friday, 30'th Sep 2022 Benzinga
Barclays cut Tilray Inc (NASDAQ: TLRY) price target from $4.5 to $2. Barclays analyst Gaurav Jain maintained an Underweight rating on the stock. Tilray Brands shares rose 0.3% to $2.87 in pre-market
NuVasive (NUVA) Down 16.2% Since Last Earnings Report: Can It Rebound?
03:32pm, Friday, 02'nd Sep 2022 Zacks Investment Research
NuVasive (NUVA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Twitter, Zoom Video And Some Other Big Stocks Moving Lower On Tuesday
04:46pm, Tuesday, 23'rd Aug 2022 Benzinga
GigaCloud Technology Inc. (NASDAQ: GCT) fell 29.9% to $29.01 after declining around 14% on Monday.
Foghorn Therapeutics Inc. (NASDAQ: FHTX) fell 23.1% to $11.30 after the company announced the FDA ha
NuVasive (NUVA) Q2 Earnings Miss Estimates, Revenues Beat
04:29pm, Monday, 08'th Aug 2022 Zacks Investment Research
NuVasive's (NUVA) Q2 revenues outpaced the consensus mark with strong sales across U.S. Spinal Hardware and Surgical Support businesses.
NuVasive (NUVA) Q2 Earnings Miss Estimates, Revenues Beat
01:33pm, Monday, 08'th Aug 2022
NuVasive's (NUVA) Q2 revenues outpaced the consensus mark with strong sales across U.S. Spinal Hardware and Surgical Support businesses.
NuVasive (NUVA) Lags Q2 Earnings Estimates
10:15pm, Wednesday, 03'rd Aug 2022 Zacks Investment Research
NuVasive (NUVA) delivered earnings and revenue surprises of -14.55% and 1.51%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
NuVasive, Inc. (NUVA) CEO Chris Barry on Q2 2022 Results - Earnings Call Transcript
09:37pm, Wednesday, 03'rd Aug 2022
NuVasive, Inc. (NASDAQ:NUVA ) Q2 2022 Earnings Conference Call August 3, 2022 4:30 PM ET Company Participants Juliet Cunningham – Vice President-Investor Relations Chris Barry – Chief Executive Of
NuVasive (NUVA) Lags Q2 Earnings Estimates
07:33pm, Wednesday, 03'rd Aug 2022
NuVasive (NUVA) delivered earnings and revenue surprises of -14.55% and 1.51%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
MedTech Stocks to Watch for Earnings on Aug 3
05:13pm, Tuesday, 02'nd Aug 2022 Zacks Investment Research
MedTech players are likely to have benefited from the consistent opening of economies and sales contributions from high testing demand. Let's see how CRL, CVS, BRKR and NUVA fare this time.
Analysts Estimate MacroGenics (MGNX) to Report a Decline in Earnings: What to Look Out for
02:01pm, Monday, 01'st Aug 2022 Zacks Investment Research
MacroGenics (MGNX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: NuVasive (NUVA) Q2 Earnings Expected to Decline
02:01pm, Wednesday, 27'th Jul 2022 Zacks Investment Research
NuVasive (NUVA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
NUVA vs. RMD: Which Stock Should Value Investors Buy Now?
03:40pm, Tuesday, 05'th Jul 2022 Zacks Investment Research
NUVA vs. RMD: Which Stock Is the Better Value Option?
